Assembly Biosciences (ASMB) on Friday announced the pricing of an underwritten, registered offering consisting of close to 5.6 million common shares and pre-funded warrants to purchase about 1.04 million common shares.
It added that the offering also includes Class A and Class B warrants to acquire up to 6.6 million common shares, priced at a combined $19.60 per common share with accompanying warrants, and $19.599 per pre-funded warrant with accompanying warrants.
The company also said Gilead Sciences will purchase close to 2.3 million shares of common stock and accompanying Class A warrants and Class B in a private placement at a similar price of $19.60 per share.
Assembly Biosciences shares were up 8.2% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。